Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as adjuvant for ulnar nerve block: dose-finding in healthy volunteers
2013-003790-10Phase 4Completed
- Sponsor
- Department of Clinical Pharmacology, Medical University of Vienna
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in pain (4 arms), sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Primary endpoint: Effect of dexmedetomidine as adjuvant on duration of peripheral nerve blockade. Started Sep 2013; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on 2013-003790-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003790-10.